Biora Therapeutics Inc. (NASDAQ: BIOR) closed the day trading at 0.62 down -5.25% from the previous closing price of $0.65. In other words, the price has decreased by $-0.0341 from its previous closing price. On the day, 1189045 shares were traded. BIOR reached its highest trading level at $0.6599 during the session, while it also had its lowest trading level at $0.6104.
For a better understanding of BIOR, let’s look at its different ratios.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 05 when Sarna Surbhi sold 7,517 shares for $0.61 per share. The transaction valued at 4,585 led to the insider holds 148,774 shares of the business.
For the stock, the TTM Price-to-Sale (P/S) ratio is 149.24.
Stock Price History:
Over the past 52 weeks, BIOR has reached a high of $6.20, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 0.7577, while the 200-Day Moving Average is calculated to be 1.1919.
Over the past 3-months, BIOR traded about 2.00M shares per day on average, while over the past 10 days, BIOR traded about 826.81k shares per day. A total of 184.37M shares are outstanding, with a floating share count of 167.43M. Insiders hold about 2.70% of the company’s shares, while institutions hold 28.40% stake in the company. Shares short for BIOR as of Jul 14, 2022 were 17.91M with a Short Ratio of 7.38, compared to 17.49M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 9.72% and a Short% of Float of 10.76%.
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of $-0.12 for the current quarter, with a high estimate of $-0.11 and a low estimate of $-0.13, while EPS last year was $-1.23. The consensus estimate for the next quarter is $-0.1, with high estimates of $-0.09 and low estimates of $-0.12.
Analysts are recommending an EPS of between $-0.36 and $-0.49 for the fiscal current year, implying an average EPS of $-0.42. EPS for the following year is $-0.37, with 2 analysts recommending between $-0.26 and $-0.49.
A total of 2 analysts have provided revenue estimates for BIOR’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $100k. In the same quarter a year ago, actual revenue was $25.61M, down -99.60% from the average estimate.